IDiyas

For the Inventor, By the Inventor

West Haven, CT, United States of America

William Harrison Bullock

USPTO Granted Patents = 7

Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 60(Granted Patents)


Location History:

  • West Haven, CT (US) (1998 - 1999)
  • Hamden, CT (US) (1998 - 2000)

Company Filing History:

goldMedal7 out of 1,008 
 
Bayer Corporation
 patents

Years Active: 1998-2000

Loading Chart...
7 patents (USPTO):Explore Patents
1. 6166082 - Substituted 5-biarylpentanoic acids and derivatives as matrix (2000-12-26),
2. 5886043 - Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease (1999-03-23),
3. 5886024 - Thiophene-containing butonic acid derivatives as matrix metalloprotease (1999-03-23),
4. 5886022 - Substituted cycloalkanecarboxylic acid derivatives as matrix (1999-03-23),
5. 5859047 - Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease (1999-01-12),
6. 5854277 - Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors (1998-12-29),
7. 5789434 - Derivatives of substituted 4-biarylbutyric acid as matrix (1998-08-04),

Title: The Innovations of William Harrison Bullock

Introduction

William Harrison Bullock is a notable inventor based in West Haven, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of matrix metalloprotease inhibitors. With a total of 7 patents to his name, Bullock's work has the potential to impact various physiological conditions.

Latest Patents

Bullock's latest patents include innovative compounds such as substituted 5-biarylpentanoic acids and derivatives. These compounds serve as matrix inhibitors for matrix metalloproteases and are included in pharmaceutical compositions designed to treat a variety of physiological conditions. The generalized formula for these compounds showcases their complexity and potential efficacy in medical applications.

Career Highlights

Throughout his career, Bullock has been associated with Bayer Corporation, where he has contributed to groundbreaking research and development. His work has not only advanced the understanding of matrix metalloproteases but has also paved the way for new therapeutic approaches in medicine.

Collaborations

Bullock has collaborated with esteemed colleagues such as Harold C. Kluender and Brian R. Dixon. These partnerships have fostered an environment of innovation and have led to the successful development of various pharmaceutical solutions.

Conclusion

William Harrison Bullock's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of treatments for various physiological conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…